Implementation and Development of Solid Organ Transplant Pharmacotherapy in Iran

• Main Author: Simin Dashti-Khavidaki (Author)
• Format: Book
• Published: Research Center for Rational Use of Drugs (RCRUD), 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2322-4630; 2322-4509
• Keywords: Clinical pharmacy; Pharmacotherapy; Solid organ transplant pharmacist; SOT pharmacotherapy; Transplant pharmacist; Therapeutics. Pharmacology; RM1-950; Pharmacy and materia medica; RS1-441
• Source: Journal of Pharmaceutical Care, Vol 11, Iss 4 (2023)

Clinical solid organ transplant (SOT) pharmacy services started half a century ago in United States (US). In 2004, United Network of Organ Sharing (UNOS) bylaws mandated all SOT programs to recognize pharmacist as a responsible for providing pharmaceutical care to SOT patients. Soon after that, SOT pharmacy services were implemented in Iran and nowadays SOT pharmacists are members of SOT multidisciplinary teams with various clinical, education, and research duties during pre-, peri-, and post-transplantation phases. Board Certification in Solid Organ Transplant Pharmacotherapy (BCTXP) was established in 2018 in the US. The aim of this postdoctoral program is providing SOT pharmacotherapy services for all patients from pre-transplantation era to decades after transplantation event in community and hospitals. Inspiring that, SOT pharmacotherapy fellowship has been programmed in Tehran University of Medical Sciences and is under consideration by National Board of Clinical Pharmacy and Ministry of Health and Medical Education of Iran. Hopefully, this program will be initiated with the first applicants among board certified clinical pharmacists from Fall 2024.